Inhalable metal organic framework (MOF) aerosols have been developed via spray drying as a therapy for multi-drug resistant (MDR) tuberculosis (TB). The CuPOA2 (pyrazinoate acid) MOFs can be tailored to exhibit a respirable mass median aerodynamic diameter (MMAD) of 2.6 μm. This method is repeated to manufacture Gd0.1Cu0.9(POA)2 MOFs for inhalable theragnostics. This journal is
CITATION STYLE
Luz, I., Stewart, I. E., Mortensen, N. P., & Hickey, A. J. (2020). Designing inhalable metal organic frameworks for pulmonary tuberculosis treatment and theragnostics: Via spray drying. Chemical Communications, 56(87), 13339–13342. https://doi.org/10.1039/d0cc05471b
Mendeley helps you to discover research relevant for your work.